FWA
GILD icon

FSC Wealth Advisors’s Gilead Sciences GILD Stock Holding History

FSC Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-144
Closed -$16.2K – 144
2025
Q1 		$16.2K Buy
144
+1
+0.7% +$103 0.01% 179
2024
Q4 		$13.2K Sell
143
-7
-5% -$630 0.01% 183
2024
Q3 		$12.6K Buy
150
+1
+0.7% +$76 0.01% 184
2024
Q2 		$10.2K Buy
149
+2
+1% +$133 0.01% 195
2024
Q1 		$10.8K Sell
147
-1
-0.7% -$77 0.01% 190
2023
Q4 		$12K Hold
148
– – 0.01% 192
2023
Q3 		$11.1K Buy
+148
New +$11.4K 0.01% 162

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

FSC Wealth Advisors's GILD Position: Q2 2025 in Review

FSC Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 144 shares — an estimated $16.2K sold.

FSC Wealth Advisors first reported a position in GILD in Q3 2023 and held it in 7 quarters. The position peaked at $16.2K in Q1 2025. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • FSC Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • FSC Wealth Advisors sold 144 Gilead Sciences shares in Q2 2025, an estimated $16.2K.
  • FSC Wealth Advisors first reported a position in Gilead Sciences in Q3 2023 and held it in 7 quarters.
  • FSC Wealth Advisors's Gilead Sciences position peaked at $16.2K in Q1 2025.
  • 2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on FSC Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.